The Effect of Pregnancy on the Treatment of Asthma Patients with COVID-19

Introduction: COVID-19 causes a variety of clinical symptoms and infects the respiratory tract, throat, nose, and lungs, resulting in severe lung disease and death. Infections can worsen asthmatic patients' conditions. In pregnant women who have underlying diseases such as asthma, the severity and prognosis of this disease are likely to be disastrous.

Case Presentation: We present the case of an asthmatic pregnant woman infected with COVID-19 who was admitted to two hospitals in Iran. Dry coughs, dyspnea, inability to speak, numbness, and fatigue were among the patient's symptoms. The initial examination revealed a body temperature of 37.9C, oxygen saturation (SPO2) 91%, partial pressure of oxygen (Pao2) was 25mm Hg, respiratory rate (RR) of 20 breaths/minute(b/m), blood pressure of 100/60 mmHg, and pulse of 80 bpm(beat/minute) and fetal heart rate (FHR)=167/min. Due to foetal tachycardia, the pregnancy was terminated by caesarean section (C/S), and a healthy baby with normal range anthropometric characteristics was born. Our patient had leukopenia, as well as high levels of C-reactive protein and erythrocyte sedimentation rate. Our patient received supportive care as well as antibiotic and antiviral therapy and was discharged in good general condition after 8 days.

Conclusions: The patient’s condition improved after 8 days of hospitalization and the patient underwent good clinical outcome in spite of underlying disease and infection with COVID-19.